Combined carbon ion radiotherapy and immunotherapy: leveraging the immunological advantages of carbon ion
Authors:
Open Access
- 25 February 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 17, 1747607
Abstract
Immunotherapy represents a systemic approach to cancer treatment; however, its effectiveness can be limited by intrinsic tumor resistance or immunosuppressive mechanisms within the tumor microenvironment. In contrast, carbon ion radiotherapy (CIRT) demonstrates considerable immunomodulatory potential owing to its distinct biological properties. The exposure of tumor-associated antigens, increased immune cell infiltration and activity, and modifications in the immune microenvironment after CIRT provide a mechanistic rationale for combining CIRT with immunotherapy. Furthermore, strategies aimed at converting the tumor microenvironment from immunosuppressive to immunostimulatory, or those targeting immune checkpoints, are currently under active exploration. This review summarizes the latest advances in combining heavy ion radiotherapy with immunotherapy, encompassing both preclinical and clinical studies. Based on the immunological advantages of CIRT, it provides a comprehensive summary and in-depth exploration of the potential of this combined treatment modality for future clinical applications, along with a theoretical foundation to support it.Keywords
This publication has 118 references indexed in Scilit:
- NKG2D CAR-NK adoptive cellular immunotherapy combined with or without PD-1 blockade in the treatment of patients with metastatic colorectal cancer: an exploratory studyCancer Immunology, Immunotherapy, 2025
- Cadonilimab, a PD-1/CTLA-4 bispecific antibody in unresectable hepatocellular carcinoma: a real-world studyCancer Immunology, Immunotherapy, 2025
- A protocol for a randomized trial evaluating the role of carbon‐ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinomaCancer Medicine, 2024
- High-LET charged particles: radiobiology and application for new approaches in radiotherapyStrahlentherapie und Onkologie, 2023
- Carbon ion radiotherapy combined with immunotherapy: synergistic anti-tumor efficacy and preliminary investigation of ferroptosisCancer Immunology, Immunotherapy, 2023
- Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancerJournal of Cancer Research and Clinical Oncology, 2022
- Engineering a Smart Agent for Enhanced Immunotherapy Effect by Simultaneously Blocking PD‐L1 and CTLA‐4Advanced Science, 2021
- Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non–Small Cell Lung CancerJAMA Oncology, 2020
- Association between radiotherapy-induced alteration of programmed death ligand 1 and survival in patients with uterine cervical cancer undergoing preoperative radiotherapyStrahlentherapie und Onkologie, 2020
- Are 90% of deaths from cancer caused by metastases?Cancer Medicine, 2019